Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

[Active interventions in hypercholesteroloemia patients with high cardiovascular risk in primary care; estudio ESPROCOL].

Tárraga López PJ, García-Norro Herreros FJ, Tárraga Marcos L, Solera Albero J, González López E, Ruiz García A, Pallarés Carratalá V, Castro Navarro JL, Alins Presas J, Panisello Royo JM.

Nutr Hosp. 2015 Jun 1;31(6):2727-34. doi: 10.3305/nh.2015.31.6.8998. Spanish.

2.

[Active interventions in hypercholesteroloemia patients with high cardivascular risk in primary care].

Tárraga López PJ, Garcia-Norro Herreros FJ, Tárraga Marcos L, Solera Albero J, González López E, Ruiz García A, Pallarés Carratalá V, Castro Navarro JL, Alins Presas J, Panisello Royo JM.

Nutr Hosp. 2015 May 1;31(5):2261-8. doi: 10.3305/nh.2015.31.5.8795. Spanish.

3.

A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap study.

Gómez-Gerique JA, Alvarez-Sala LA, Armada B, Fernández-Arias I, Martinez J, Hernández G; CHEAP Study Group.

Curr Ther Res Clin Exp. 2003 Jun;64(6):338-54. doi: 10.1016/S0011-393X(03)00090-0.

5.

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

JAMA. 2002 Dec 18;288(23):2998-3007.

PMID:
12479764
6.

[Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].

Brath H, Wascher TC, Kästenbauer T, Toplak H.

MMW Fortschr Med. 2012 Jun 28;154 Suppl 2:41-7. German.

PMID:
23424754
7.

[Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].

Pérez A, González Blanco C, Hernández-Presa MÁ, Chaves J.

Endocrinol Nutr. 2011 Jun-Jul;58(6):283-90. doi: 10.1016/j.endonu.2011.03.005. Spanish.

PMID:
21641286
8.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

9.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

PMID:
15297292
10.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

PMID:
15249516
11.

Metabolic control and chronic complications during a 3-year follow-up period in a cohort of type 2 diabetic patients attended in primary care in the Community of Madrid (Spain).

Arrieta F, Piñera M, Iglesias P, Nogales P, Salinero-Fort MA, Abanades JC, Botella-Carretero JI, Calañas A, Balsa JA, Zamarrón I, Rovira A, Vázquez C; ESD2 Group.

Endocrinol Nutr. 2014 Jan;61(1):11-7. doi: 10.1016/j.endonu.2013.09.002. Epub 2013 Oct 30.

PMID:
24182687
13.

[Cholesterolemia control in Spain, 2000: a tool for cardiovascular disease prevention].

Plaza Pérez I, Villar Alvarez F, Mata López P, Pérez Jiménez F, Maiquez Galán A, Casasnovas Lenguas JA, Banegas Banegas JR, Tomás Abadal L, Rodríguez Artalejo F, Gil López E.

Rev Clin Esp. 2000 Sep;200(9):494-515. Review. Spanish.

PMID:
11111397
14.

Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.

Amariles P, Sabater-Hernández D, García-Jiménez E, Rodríguez-Chamorro MÁ, Prats-Más R, Marín-Magán F, Galán-Ceballos JA, Jiménez-Martín J, Faus MJ.

J Manag Care Pharm. 2012 May;18(4):311-23.

15.

[Lipid control in secondary prevention: multicenter observational study in primary care].

Brotons C, Maiques A, Mostaza J, Pintó X, Vilaseca J; Estudio EMOSCOL.

Aten Primaria. 2004 Jun 30;34(2):81-6. Spanish.

16.

[Factors predictive of cardiovascular disease in patients with type-2 diabetes and hypercholesterolemia. ESODIAH study].

Pintó X, Corbella E, Figueras R, Biarnés J, Ricart W, Morales C, Falkon L, Masana L; ESODIAH study group.

Rev Esp Cardiol. 2007 Mar;60(3):251-8. Spanish.

17.
18.

[Analysis of Secondary Data to Determine the Prevalence of Cardiovascular High Risk Patients with Hypercholesterolemia and Refractory Course of Treatment].

Dippel FW, Parhofer KG, Müller-Bohn T, Gebhardt S, Kostev K.

Dtsch Med Wochenschr. 2017 Mar;142(6):e34-e41. doi: 10.1055/s-0042-123977. Epub 2017 Mar 22. German.

PMID:
28329898
19.

[Control of cholesterolemia in Spain, 2000. A tool for cardiovascular prevention].

Plaza Pérez I, Villar Alvarez F, Mata López P, Pérez Jiménez F, Maiquez Galán A, Casasnovas Lenguas JA, Banegas Banegas JR, Tomás Abadal L, Rodríguez Artalejo F, Gil López E.

Rev Esp Cardiol. 2000 Jun;53(6):815-37. Review. Spanish.

20.

Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care.

Hildemann S, Karmann B, Pittrow D, Barho C, Darius H, Bode C.

Curr Med Res Opin. 2008 Jun;24(6):1659-68. doi: 10.1185/03007990802134755. Epub 2008 May 2.

PMID:
18457604

Supplemental Content

Support Center